Literature DB >> 6854762

Antidiuretic hormone levels and the effect of indomethacin on ureteral colic.

L Grenabo, M Aurell, K Delin, D Holmlund, J G Sjödin.   

Abstract

We treated 25 patients with ureteral colic and urographically verified stones with 50 mg. indomethacin intravenously. Pain was relieved completely in 17 patients, while in 8 incomplete or no pain relief was achieved after the infusion of indomethacin. Patients completely relieved of pain had significantly higher levels of antidiuretic hormone in plasma before the infusion of indomethacin (18.2 plus or minus 3.4 pg./ml.) than patients with incomplete or no pain relief (7.2 plus or minus 1.3 pg./ml.) (p less than 0.01). These findings indicate that the volume status and/or the level of antidiuretic hormone may be of critical importance for pain relief after infusion of indomethacin in patients with ureteral colic.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854762     DOI: 10.1016/s0022-5347(17)52468-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  A comparative assessment of the clinical efficacy of intranasal desmopressin spray and diclofenac in the treatment of renal colic.

Authors:  Santosh Kumar; Nimai Charan Behera; Debansu Sarkar; Seema Prasad; Arup Kumar Mandal; S K Singh
Journal:  Urol Res       Date:  2011-01-14

2.  Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion.

Authors:  D Debruyne; B Hurault de Ligny; J P Ryckelynck; F Albessard; M Moulin
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

3.  Sublingual desmopressin is efficient and safe in the therapy of lithiasic renal colic.

Authors:  Catalin Pricop; Dumitru D Branisteanu; Martha Orsolya; Dragos Puia; Anca Matei; Ionel Alexandru Checherita
Journal:  Int Urol Nephrol       Date:  2015-12-16       Impact factor: 2.370

4.  Clinical efficacy of Spasmofen® suppository in the emergency treatment of renal colic: a randomized, double-blind, double-dummy comparative trial.

Authors:  Mostafa Yakoot; Amel Salem; Sameh Yousef; Sherine Helmy
Journal:  Drug Des Devel Ther       Date:  2014-05-02       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.